CLEO DIAGNOSTICS LTD (COV)
AI Coverage Rating: Moderate
ASX AI Signals has generated 1 signal(s) for COV during the last 90 days,
indicating Moderate trading activity
Latest COV Signals |
| 12/05/2026 | BUY |
COV Share Price |
| Current Price | $0.500 |
| 52 Week High | $0.865 |
| 52 Week Low: | $0.335 |
| Trading at (% of 52 Week High) | 57.80% |
Volume
95648
20 Day Avg
117067
Relative Volume
81.7%
Business Overview
Cleo Diagnostics Ltd (ASX: COV) is a healthcare technology company that develops and commercializes rapid diagnostic tests. The company focuses on providing point-of-care testing solutions for infectious diseases and other health conditions to improve patient outcomes.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The BUY signal for CLEO DIAGNOSTICS LTD (COV) is supported by positive momentum and potential growth in the diagnostics sector. However, the relatively low current price and limited market capitalization introduce moderate risk, warranting a cautious approach.
Latest CLEO DIAGNOSTICS LTD(COV) News
16 Jan 2026, 02:08 PM
The Australian market today presents a mixed outlook, with the Aussie dollar inching closer to 67 cents against the USD and equities poised for a flat opening. For investors interested in exploring beyond well-known names, penny stocks—typically smaller or newer companies—offer intriguing possib
24 Nov 2025, 07:01 AM
The Australian market is experiencing a challenging period, with futures indicating a significant downturn and volatility on the rise. Despite these turbulent conditions, penny stocks—though an old-fashioned term—remain an intriguing area for investors seeking value in smaller or newer companies
24 Oct 2025, 07:02 AM
The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term "penny sto
17 Sep 2025, 01:05 PM
As Australian shares edge towards a slight dip, global markets remain on edge awaiting the Federal Reserve's anticipated rate cut decision. Amidst these market fluctuations, the term "penny stocks" may seem outdated, yet they continue to offer intriguing opportunities for investors seeking affordabl
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial